Notice Title

Consent to the Distribution of a New Medicine

Publication Date
14 Sep 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go4299
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Veklury
Active Ingredient: Remdesivir 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Gilead Sciences (NZ)
Manufacturers: Patheon Manufacturing Services LLC, North Carolina, United States of America
Hikma Farmaceutica (Portugal) Lda, Terrugem, Portugal
Jubilant HollisterStier LLC, Washington, United States of America
Patheon Italia S.p.A, Milan, Italy


Dated this 14th day of September 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).